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Background: This study aimed to analyze the efficacy of an anti-calculus mouth rinse and its possible adverse 
effects on the mucosa and teeth. 
Material and Methods: This randomized double-blind placebo-controlled clinical trial included 40 patients with 
treated and managed periodontal disease, all with a history of rapid calculus formation. Patients used a pyrophos-
phate-based test mouth rinse (B) or a placebo (A). A range of parameters were measured for: saliva (saliva flow, 
pH and chemical composition); calculus (Volpe-Manhold [V-M] index, weight, and volume); adverse effects on 
mucosa and teeth; and the patients’ subjective perceptive of mouth rinse efficacy. 
Results: the test mouth rinse B produced reductions in urea, uric acid, and phosphorous, calcium, saliva flow, 
and increases in pH. V-M index and calculus weight decreased after using the test mouth rinse. Calculus volume 
decreased with both mouth rinses. No changes to the mucosa or teeth were observed. Patients perceived that the 
test mouth rinse was more effective. 
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Introduction
Dental calculus is the consequence of the mineraliza-
tion of bacterial plaque, which compromises oral health 
as it increases the accumulation of plaque and bacte-
rial toxins and impedes their removal due to the sur-
face roughness it produces. For this reason, calculus 
prevents the patient from maintaining an effective oral 
hygiene regime, which then facilitates the formation of 
further plaque (1).
The main periodontal diseases – gingivitis and peri-
odontitis – have been related to the accumulation of 
dental plaque among other factors (2). Calculus ac-
cumulation varies across the general population. One 
group of individuals are known as ‘rapid calculus form-
ers’ who, in spite of maintaining good plaque control, 
need frequent visits to the dentist to manage the rapid 
formation of supragingival calculus (1). 
To deal with this problem, a large range of products have 
been marketed in recent years (mouth rinses, toothpastes, 
chewing gums, etc.). Numerous studies have shown that 
pyrophosphates, commonly used in these products, re-
duce the percentage of calculus formed (3-8). Neverthe-
less, in rapid calculus formers these products are not 
enough to deal with the problem. These patients continue 
to require frequent visits to the dentist to maintain ad-
equate oral health. In this context, the results of trials of 
anti-calculus products are limited, suggesting the need 
for further research in this field (9). 
The main aim of this study was to evaluate the magnitude 
of calculus formation after using a pyrophosphate-based 
anticalculus mouth rinse in order to assess its efficacy 
and possible adverse effects on the mucosa and teeth. 
Specific objectives were to: 1. Measure the volume, pH, 
and chemical composition of saliva to determine wheth-
er use of the mouth rinse modified saliva and whether 
there was any relation between saliva modification and 
the quantity of calculus formed; 2. To assess the effects 
of the pyrophosphate-based mouth rinse on the bacte-
rial plaque microorganisms associated with calculus 
formation (Eubacterium Saburreum, Corynebacterium 
matruchotii, Veillonella parvula, streptococcus salivar-
ius, Streptococcus sanguis and Streptococcus mutans).
Material and Methods 
The present study, conducted at the Stomatology De-
partment, Faculty of Medicine and Dentistry, at the 
Conclusions: The test/B and placebo mouth rinses both modified certain parameters in saliva composition, particu-
larly reductions in urea, uric acid, and phosphorous. Calcium tended to increase after using the test-B mouth rinse. 
The results did not demonstrate the anticalculus efficacy of the pyrophosphate-based mouth rinse or positive effects 
on saliva flow or composition. This field requires further research, as no product has been developed that prevents 
calculus formation completely.  
Key words: Dental calculus, anticalculus mouth rinse, Volpe Manhold index.
University of Valencia (Spain), set out to study the ef-
ficacy of a pyrophosphate-based mouth rinse marketed 
by Dentaid (Barcelona, Spain) for inhibiting calculus 
formation among a group of rapid calculus formers.  
This randomized, double-blind, placebo-controlled, 
clinical trial was approved by the University of Valencia 
Ethics Committee and fulfilled Declaration of Helsinki 
and European Council guidelines for research involving 
human subjects, as well Spanish legislation applying to 
biomedical research, data protection, and bioethics. All 
patients selected to participate presented (treated and 
managed) periodontal disease and a history of rapid 
calculus formation. Each patient was provided with full 
information about the study procedures and objectives 
and all signed an informed consent form. 
Subjects used both the test mouth rinse (B) which con-
tained pyrophosphate-based formula (0.85% Tetrasodi-
um pyrophosphate decahydrate; 0.5% Sodium Hexam-
etaphosphate; 0.5% Sodium Tripolyphosphate 0.50%; 
0.05% Sodium Fluoride [226 ppm of F ions]) and a 
placebo mouth rinse (A) with the same composition as 
the test mouth rinse B but without the main active in-
gredients. Both had the same organoleptic properties 
so that neither subjects nor clinicians could distinguish 
between them.  All patients used both mouth rinses 
throughout the study period, using the test product for 
a time and the placebo at another; this was designed to 
maximize sample size, given the difficulties of locat-
ing numbers of rapid calculus formers who also present 
good oral hygiene maintenance.  The order in which the 
mouth rinses were used was randomized. 
Initial supragingival scaling was performed, and then 
each mouth rinse was used for three months. Scaling 
and polishing were repeated between mouth rinses (test 
B / placebo A), when patients spent 24 hours without 
using any mouth rinse.  
To ensure that patients had followed the mouth rinse re-
gime correctly, a measured quantity of mouth rinse was 
delivered to each patient, providing a specific amount to 
cover each day of mouth rinse use; patients were asked 
to return any leftovers at the end of the 3-month period. 
Throughout the study, all patients used the same tooth-
brush (Vitis® suave, Dentaid®, Cerdanyola, Barcelona, 
Spain) and the same toothpaste (Vitis® encías, Den-
taid®). 
Inclusion criteria were as follows: patients who had 
Med Oral Patol Oral Cir Bucal. 2019 Sep 1;24 (5):e621-9.                                                                                                                                 Capacity of pyrophosphates to inhibit dental calculus
e623
completed treatment for active periodontal disease; pa-
tients in the maintenance phase for at least 2 months be-
fore the start of the study; patients with a demonstrable 
history of rapid calculus formation; patients presenting 
stable clinical insertion levels and probing depth of 3 
mm or less in the fifth sextant (at least); patients willing 
to adhere strictly to the study protocol. Exclusion crite-
ria were: patients with missing teeth in the fifth sextant; 
the presence of systemic disorders that could modify sa-
liva flow or have some repercussion for periodontal tis-
sue; patients with poor plaque control (Silness and Löe 
plaque index >1 in test teeth); patients taking medica-
tion (antibiotics, anti-inflammatories, anti-depressives) 
or using mouth rinses (antiseptic or anticalculus mouth 
rinses) for 3 months before the start of the study; pa-
tients presenting localized factors that might influence 
plaque retention such as fillings, orthodontic apparatus, 
temporary or definitive splints/guards, fixed or remov-
able prostheses.  
A series of parameters were registered for saliva and 
calculus measurement to analyze the efficacy of the 
mouth rinses from different perspectives. Salivary pa-
rameters were: saliva flow in repose, measured using 
the drainage technique; pH, measured using a digital 
pH-meter (PCE Group, Albacete, Spain); and chemical 
analysis performed at a hospital center (Hospital La Fe, 
Valencia, Spain) to determine concentrations of urea, 
uric acid, calcium, phosphate, sodium, potassium and 
chlorine (two self-analyzers were used: 1. Modular An-
alytics SWA, Hitachi 917 [Roche®, Basle, Switzerland]; 
2. BNII® DadeBehring [Siemens®, Berlin, Germany]). 
Supragingival bacterial plaque analysis: a sample of 
bacterial plaque was harvested from the fifth sextant. 
Plaque was collected during all patient examinations, 
from the lingual and vestibular faces of the test teeth 
using a sterile curette and placing the sample in con-
servation solution (reduced transport fluid [RTF]) in an 
Eppendorf tube for later analysis. All samples were sent 
to a laboratory (Laboral, Barcelona, Spain) for analysis 
to determine the weight and volume of calculus and the 
presence of bacteria: Eubacterium saburreum, Coryne-
bacterium matruchotii, Veillonella parvula, Streptococ-
cus salivarius, Streptococcus sanguis and Streptococ-
cus mutans. 
The Volpe-Manhold index was used to measure the 
magnitude of calculus formation; it was weighed with 
analysis scales (PCE Group®, Albacete, Spain) and its 
volume measured with a pycnometer (Afora®, Barcelo-
na, Spain). For measurement, the calculus was detached 
from the dental surface with an ultrasonic air scaler 
(SONICflex®, KaVo Dental, Fruehauf Drive, Charlotte, 
USA) and collected with a bone aspirator (Onmia,® 
Proclinic, Barcelona, Spain).
Lastly, possible changes to the oral mucosa and teeth 
were assessed visually. 
Patients’ subjective perceptions of the efficacy of the 
mouth rinses were registered by means of a question-
naire.
Descriptive statistics of the parameters and differences 
between mouth rinses (placebo A and test B) were calcu-
lated: mean, standard deviation, minimum, maximum, 
median, and absolute and relative frequencies. Normal 
distribution of continuous measurements was checked 
with the Kolmogorov-Smirnov test. Inferential analysis 
was performed to determine the existence of significant 
differences in response parameters due to the mouth 
rinse used (placebo A/test B). A general linear model of 
repeated measures was estimated for response variables 
showing normal distribution. The efficacy of the test 
mouth rinse was assessed by means of the intra-subject 
interaction evaluated by Pillai’s trace value associated 
F-statistic. The Bonferroni test was used for post-hoc 
multiple comparisons to evaluate the changes to a pa-
rameter after using each of the mouth rinses. For other 
non-continuous indicators, or those that did not show 
normal distribution, the influence of the mouth rinses 
was evaluated by means of McNemar’s test (for changes 
in proportion) or the Wilcoxon test for paired samples 
(for changes in distribution).  Statistical significance 
was set at 5% (α=0.05).
Results
This randomized double-blind placebo-controlled clini-
cal trial assessed the efficacy of a pyrophosphate-based 
mouth rinse for inhibiting dental calculus in a sample of 
‘rapid calculus forming’ patients. Three patients were 
lost during the study period as they did not fulfill the 
study protocol, leaving a total sample of 37 subjects 
(n=37). All patients used both mouth rinses (test B and 
placebo A), so a single group constituted both control 
group (placebo A) and test group (test mouth rinse B). 
In the statistical tests applied to the data to detect dif-
ferences induced by the mouth rinses, for a paired t test 
with 5% significance level, considering an effect size of 
0.5, the power reached was 0.84. 
-Saliva Parameters 
The two mouth rinses presented very similar patterns 
in their effects on saliva composition. Sodium, chlorine 
and potassium levels were unaffected by both mouth 
rinses and remained stable throughout the study. Urea, 
uric acid and phosphorous decreased similarly with the 
use of both mouth rinses. Calcium, saliva flow, and pH 
tended to increase more with mouth rinse test-B. For 
some parameters such as calcium and saliva flow, test-
B intensified differences in final values compared with 
placebo-A. For sodium, this tendency was reversed 
(Table 1).
-Calculus dimension parameters 
Baseline mean Volpe-Manhold index was 19.70 ± 9.62, 
decreasing to 13.7 ± 7.1 units after placebo-A use and 
Med Oral Patol Oral Cir Bucal. 2019 Sep 1;24 (5):e621-9.                                                                                                                                 Capacity of pyrophosphates to inhibit dental calculus
e624
11.0 ± 6.5 units after use of the test-B mouth rinse. 
The reduction obtained with test-B mouth rinse was 
statically significant (p<0.001) but so was the reduction 
achieved with the placebo-A (p<0.001). So no definitive 
evidence was found for a reduction in calculus due to 
an exclusive effect of the test-B mouth rinse. Neverthe-
less, the magnitude of the reduction was not equal with 
both mouth rinses, whereby the test-B mouth rinse pro-
duced a significantly larger reduction than the placebo-
A (p=0.012) (Table 2). 
Calculus weight was analogous to volume in the reduc-
tions obtained by the two mouth rinses. Mean weight at 
BASELINE FINAL BASELINE-FINAL - 
difference
Mean ± sd MOUTH RINSE Mean ± sd p-value1 Mean ± sd p- value2
SALIVA FLOW 
(ml/min) 
0.51 ± 0.32 PLACEBO 0.61 ± 0.35 0.026* 0.09 ± 0.25 0.186
TEST-B 0.68 ± 0.38 0.002** 0.16 ± 0.30
PH 6.8 ± 0.6 PLACEBO 7.0 ± 0.4 0.128 0.2 ± 0.6 0.128
TEST-B 7.1 ± 0.5 0.007** 0.3 ± 0.5
UREA (mg/dl) 45.8 ± 16.4 PLACEBO 32.0 ± 5.8 <0.001** * -13.8 ± 16.8 0.109
TEST-B 35.4 ± 9.8 0.003** -10.4 ± 19.4
URIC ACID 
(mg/dl) 
3.5 ± 2.0 PLACEBO 2.5 ± 0.8 0.008** 1.0 ± 2.1 0.440
TEST-B 2.7 ± 1.2 0.002** 0.8 ± 1.5
CALCIUM 
(meq/l) 
1.8 ± 0.6 PLACEBO 2.2 ± 1.1 0.089 0.4 ± 1.3 0.081
TEST-B 2.5 ± 1.6 0.015* 0.7 ± 1.7
PHOSPHO-
ROUS (meq/l) 
20.6 ± 8.5 PLACEBO 10.2 ± 1.1 <0.001** * -10.4 ± 8.4 0.976
TEST-B 10.2 ± 0.7 <0.001** * -10.4 ± 8.6
SODIUM 
(meq/l) 
9.6 ± 4.9 PLACEBO 9.3 ± 1.1 0.753 -0.3 ± 4.9 0.324
TEST-B 9.0 ± 1.3 0.530 -0.6 ± 5.2
POTASSIUM 
(meq/l) 
31.4 ± 6.7 PLACEBO 30.5 ± 1.4 0.449 -0.9 ± 7.0 0.254
TEST-B 30.8 ± 1.8 0.673 -0.5 ± 7.1
CHLORINE 
(meq/l) 
18.5 ± 7.8 PLACEBO 19.5 ± 2.2 0.480 1.0 ± 8.2
0.387TEST-B 19.9 ± 1.7 0.324 1.4 ± 8.3 
Table 1: Saliva Parameters: Results obtained from GLM of repeated measures with intra-subject factors: time and mouth rinse; and inter-subject 
factor: the order in which mouth rinses were used.
baseline was 21.9 + 13.2 mg decreasing to 15.1 ± 10.7 
mg with use of the placebo-A, and to 10.8 ± 9.6 mg af-
ter using the test-B mouth rinse. Both reductions were 
statistically significant (placebo-A: p<0.001; test-B: 
p<0.001;), although the effect of test-B was of greater 
relevance (p=0.004).
Mean volume at baseline was 21.9 ± 12.3 mm3, decreasing 
to 14.2 ± 9.7 mm3 after using placebo-A and 14.3 ± 14.9 
mm3 after using the test-B mouth rinse. The mean de-
creases with both mouth rinses were statistically signifi-
cant (placebo-A: p<0.001; test-B: p=0.009;). Neverthe-
less, both reductions were significantly equal (p=0.989). 
1. Bonferroni test for multiple comparisons.  2. Test F for Pillai’s trace *p<0.05; **p<0.01; ***p<0.001 




% positives MOUTH RINSE % positives p-value1 % negativized / 
positivized
p- value2
E. SABORREUM 100% PLACEBO 100% 1.000 0% / --- 0.816
TEST-B 97.3% 1.000 2.7% / ---
C. MATRUCHOTTI 100% PLACEBO 100% 1.000 0% / --- 0.157
TEST-B 94.6% 1.000 5.4% / ---
V. PARVULA 100% PLACEBO 100% 1.000 0% / --- 1.000
TEST-B 100% 1.000 0% / ---
S. SANGUIS 100% PLACEBO 100% 1.000 0% / --- 1.000
TEST-B 100% 1.000 0% / ---
S. SALIVARIUS 27% PLACEBO 32.4% 0.754 10.8% / 16.2%
0.206TEST-B 43.2% 0.070 2.7% / 18.9%
S. MUTANS 
10,8%
PLACEBO 16.2% 0.625 2.7% / 8.1%
0.414TEST-B 21.6% 0.219 2.7% / 13.5% 
Table 2: Calculus parameters: Results obtained from GLM of repeated measures with intra-subject factors: time and mouth rinse; and inter-
subject factor: the order in which mouth rinses were used. 
-Supragingival bacterial plaque analysis 
Both qualitative and quantitative polymerase chain re-
action (PCR) analyses were performed to determine the 
presence or absence of bacteria and the bacterial load. 
-PCR analysis
No significant change in prevalence (positivity) was 
BASELINE FINAL
BASELINE-FINAL difference
% positives MOUTH RINSE % positives p-value1 % negativized / 
positivized
p- value2
E. SABORREUM 100% PLACEBO 100% 1.000 0% / --- 0.816
TEST-B 97.3% 1.000 2.7% / ---
C. MATRUCHOTTI 100% PLACEBO 100% 1.000 0% / --- 0.157
TEST-B 94.6% 1.000 5.4% / ---
V. PARVULA 100% PLACEBO 100% 1.000 0% / --- 1.000
TEST-B 100% 1.000 0% / ---
S. SANGUIS 100% PLACEBO 100% 1.000 0% / --- 1.000
TEST-B 100% 1.000 0% / ---
S. SALIVARIUS 27% PLACEBO 32.4% 0.754 10.8% / 16.2%
0.206TEST-B 43.2% 0.070 2.7% / 18.9%
S. MUTANS 
10,8%
PLACEBO 16.2% 0.625 2.7% / 8.1%
0.414TEST-B 21.6% 0.219 2.7% / 13.5% 
Table 3: Bacteriological parameters: prevalence.
1. McNemar’s test to determine changes in prevalence from baseline to final result. 2. Wilcoxon test to evaluate whether the evolution registered 
(negativization, stabilization, positivization) was similar with the use of both mouth rinses. *p<0.05; **p<0.01; ***p<0.001 
produced in any of the bacteria after using the either the 
placebo-A or test-B mouth rinses. The only tendency 
of note was the increase registered for S. Salivarius af-
ter using the test-B mouth rinse (p=0.070). At baseline, 
27% of patients showed positive, while after test-B use 
the percentage rose to 43.2% (Table 3).
1. Bonferroni test for multiple comparisons.  2. F test for Pillai’s trace.  3. Wilcoxon test *p<0.05; **p<0.01; ***p<0.001  
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-Bacterial load (qPCR) 
This analysis was performed only in those patients who 
presented a positive PCR and qPCR over the detec-
tion limit.  In order to make data simpler to analyze, 
CFU (colony forming units) load was transformed into 
a decimal logarithm scale, making data more manage-
able. In addition, providing the sample size is adequate, 
logarithmic transformation favors normalization of the 
original variables, stabilization of their variance, and 
parametric testing (Table 4).
BASELINE FINAL BASELINE-FINAL 
difference 
Media ± de MOUTH RINSE Mean ± sd p-value1 Mean ± sd p- value2 
EUBACTERIUM 5.10 ± 1.07 PLACEBO 5.18 ± 0.99 0.621 -0.06 ± 1.09 0.304 
TEST-B 5.29 ± 1.11 0.515 0.14 ± 0.83 
C. MATRUCHOTTI 6.34 ± 0.79 PLACEBO 6.46 ± 1.08 0.205 0.12 ± 0.97 0.780 
TEST-B 6.56 ± 0.86 0.275 0.14 ± 0.77 
V. PARVULA 7.00 ± 0.59 PLACEBO 6.95 ± 0.69 0.488 -0.05 ± 0.51 0.680 
TEST-B 6.99 ± 0.67 0.912 -0.01 ± 0.63 
S. SANGUIS 8.67 ± 0.60 PLACEBO 8.67 ± 0.66 0.973 0.00 ± 0.69 0.853 
TEST-B 8.65 ± 0.61 0.801 0.03 ± 0.64 
S. SALIVARIUS 6.04 ± 1.13 PLACEBO 6.06 ± 1.20 1.000 (3) 0.17 ± 2.29 0.655 (3) 
TEST-B 6.21 ± 0.78 0.866 (3) 0.05 ± 1.20 
S. MUTANS 4.25 ± 0.70 PLACEBO 4.32 ± 0.54 0.655 (3) -0.08 ± 0.44 0.614 (3) 
TEST-B 4.64 ± 0.91 0.655 (3) 0.05 ± 1 
Table 4: Bacterial parameters: transformed decimal logarithm scale of CFU load. Results obtained from GLM of repeated measures with 
intra-subject factors: time and mouth rinse; and inter-subject factor: the order in which mouth rinses were used for the bacteria: Eubacterium, 
Matruchotti, V. parvula and S. sanguis. Results of Wilcoxon test for S. salivarius and S.mutans. Baseline: patients above detection level qPCR. 
1. McNemar test *p<0.05; **p<0.01; ***p<0.001 
In terms of both prevalence and absolute bacterial load, 
neither mouth rinse appeared to induce relevant varia-
tions in the bacterial species analyzed. 
-Product tolerance parameters 
Under clinical examination, no anomalies were ob-
served in photographs taken at different stages of the 
study. Three patients reported canker sores after using 
the test-B mouth rinse and one after using the placebo, 
but also mentioned that they occasionally suffered these 
sores when not using mouth rinses. In the same way, 
some patients reported staining but these individuals 
also underwent staining from time to time regardless 
of mouth rinse use; staining was not seen to increase 
or decrease as a result of the study mouth rinses. The 
mouth rinses did not appear to have any effects on hard 
tissues or the oral mucosa.  
-Subjective perception of mouth rinse efficacy 
The questionnaire to assess the efficacy of the mouth 
rinse for preventing calculus formation found that 
51.3% of patients reported forming less calculus than 
normal with the test-B mouth rinse, while 8.1% reported 
less calculus with the placebo-A, and 37.8% found both 
mouth rinses effective for preventing calculus forma-
tion; 2.7% said that neither mouth rinse was effective 
(Table 5).
Discussion
The present study investigated a sample of 37 patients 
(three were lost through failure to fulfill the study pro-
tocol). This number was sufficient to perform statistical 
analysis and detect significant differences between the 
mouth rinses assayed, reaching a statistical power of 
0.84. Most similar studies have had larger sample sizes, 
although in some, the level of oral hygiene maintenance 
among the rapid calculus formers was not checked (10), 
and in others the sample consisted of all kinds of pa-
tients rather than rapid calculus formers exclusively 
(3,7). It was not easy to recruit numbers of patients who 
were rapid calculus formers and also maintained good 
plaque control, but these criteria constituted an impor-
tant characteristic of the present study. Oral hygiene is 
usually linked to the amount of calculus formed, so the 
combination of good plaque control and major calculus 
formation is unusual.  
To measure calculus quantity, the methods used in pre-
vious research were identified and assessed through an 
extensive literature search. There are various indices 
used for measuring calculus: the Volpe-Manhold index, 
the marginal line calculus index, the calculus surface 
index, etc. Among these methods, the Volpe-Manhold 
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FINAL
MOUTH RINSE % who reported effect p-value1 
ITCHING PLACEBO 0.0% 1.000 
TEST-B 2.7% 
STINGING PLACEBO 0.0% 1.000 
TEST-B 5.4%
BURNING PLACEBO 5.4% 1.000 
TEST-B 2.7% 
IRRITATION PLACEBO 2.7% 1.000
TEST-B 0.0% 
PLEASTANT TASTING PLACEBO 83.8% 1.000 
TEST-B 86.5%
Table 5: Subjective perception parameters: frequency of reactions. 
is the most frequently employed in trials of anticalcu-
lus products (3,5,7,11-13). In addition, the present study 
measured both the weight and volume of calculus, a 
novel feature not found in previous studies with similar 
characteristics. 
The method used for collecting calculus was similar to 
that used in a study by Grases et al. (14), although in the 
earlier work calculus underwent chemical analysis and 
was not quantified as in the present study. 
Calculus measurement was performed on six lower 
anterior teeth as this is the area where the most supra-
gingival calculus is deposited (15,16) and previous tri-
als of anticalculus products have focused on this area 
(3,5,15,16).
As for the duration of mouth rinse use, in most other 
studies the time passed between the start of the study 
period and data collection – varying between 3 weeks 
and 2 months – has been shorter than we consider nec-
essary (3,5,7,8,14,17). But some tested the mouth rinses 
for a period of 3 months as in the present study (7,18,19). 
The reason for the 3-month period derives from the fact 
that this is the maximum time lapse between the peri-
odontal support sessions that rapid calculus formers re-
quire. In this way, it was possible to determine whether 
the mouth rinse was effective, and would allow patients 
longer intervals between dental check-ups.  
In the present study, saliva flow per minute was found 
to increase from 0.51 ± 0.32 ml/min at baseline to 0.61 ± 
0.35 ml/min after placebo-A use, and to 0.68 ± 0.38 ml/
min after test-B mouth rinse use. In comparison with 
previous studies, although some increase was observed 
in the present study, this was nowhere near the values 
obtained for stimulated saliva flow (20). 
The increase in pH after using the test-B mouth rinse 
was statistically significant compared with baseline 
level (p=0,007), an effect that was not produced by the 
placebo-A mouth rinse (p=0.128). This increase in pH 
was probably due to the increased saliva flow also pro-
duced. Dawes reported that the pH of saliva stimulated 
by chewing gum was significantly higher than non-
stimulated saliva (16). In the present study no relation 
was found between saliva pH and increased calculus 
deposits. On the contrary, according to the literature, 
calculus deposits are more related to the pH of bacterial 
plaque than salivary pH (21,22). 
The chemical values obtained fell within the range 
considered normal. It is of note that calcium, although 
within the range of normality, increased in concentra-
tion after the use of both mouth rinses, especially the 
test-B mouth rinse. Mandel (2) affirmed that calcium in 
submaxillary saliva  is significantly more abundant in 
rapid calculus formers than patients who are not, while 
Dawes noted that as the saliva flow rate increases, so do 
the mean concentrations of sodium and calcium (23). 
Regarding the somewhat inconclusive results for sali-
vary parameters, not all studies have established a di-
rect relation between saliva components and calculus 
formation and other lines of investigation place more 
importance on the chemical components of bacterial 
plaque than those of saliva (24,25). 
As for calculus quantification parameters, the mean 
baseline Volpe-Manhold index was 19.70 ± 9.62, de-
creasing to 11.0 ± 6.5 after using test B mouth rinse, 
and 13.7 ± 7.1 after the placebo-A. So a statistically sig-
nificant reduction was found for both the test-B and the 
placebo-A mouth rinse, the decrease being greater with 
the test product (reduction of 44.1%). Mallatt et al. (3) 
obtained a reduction in Volpe-Manhold index of 26% 
for a test mouth rinse (test 4.74; control 6.40). These 
Volpe-Manhold scores were lower as the subjects were 
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not rapid calculus formers and the study duration was 
shorter. Gaengler et al. (5) registered a decrease in cal-
culus of 25.5% with the use of a product compared with 
a placebo, while Llena et al. (7) registered a smaller de-
crease than the present study between baseline and final 
values (baseline 12.39; placebo 10.95; and test 9.41). 
Regarding calculus weight and volume, weight was 
seen to reduce significantly after using the test-B mouth 
rinse compared to baseline values and the placebo-
A; nevertheless, volume behaved similarly with both 
mouth rinses, although values did improve in compari-
son with baseline measurements. The fact that weight 
and volume did not correlate may be explained by the 
lower density of calculus after using the test-B mouth 
rinse.  
It can be seen that using the test mouth rinse produced 
a statistically significant decrease in calculus, but so did 
the placebo, although not of the same magnitude. This 
finding suggests that the reduction in calculus was not 
due to the mouth rinse exclusively. It could be a result 
of a boost in motivation by patients in response to par-
ticipation in a study. This is known as the Hawthorne 
effect: a modification of behavior among subjects when 
they know they are being monitored. In the present case, 
patients had been attending three-monthly oral hygiene 
check-ups for years to stabilize periodontal disease and 
had demonstrated a history of good oral hygiene (plaque 
index scores of 1 or below). Nevertheless, the placebo 
also had a beneficial effect on calculus reduction, sug-
gesting that perhaps plaque control maintained by the 
patients before the start of the study was not as good 
as we were led to believe, and so oral hygiene practices 
might have improved during the study period leading 
to reductions in calculus formation during placebo use. 
No changes to oral mucosa or hard tissues were ob-
served, a finding that concurs with the literature, which 
does not report any adverse effects derived from pyro-
phosphates (3,18,26-28). 
Conclusions
1. Both the test-B and the placebo-A mouth rinses mod-
ified certain parameters in the chemical composition 
of saliva, particularly reductions in urea, uric acid, and 
phosphorous. Calcium tended to increase with the test-
B mouth rinse. Saliva flow and pH levels increased after 
use of the test-B mouth rinse. 
2. Bacterial analysis observed a tendency for reductions 
in the presence of bacteria after using the mouth rinses, 
but neither the prevalence nor the bacterial load under-
went statistically significant changes. 
3. Oral mucosa and teeth were unaffected by the use of 
either mouth rinse. 
4. The pyrophosphate-based mouth rinse was not shown 
to have anticalculus effects or any positive effects on 
saliva flow or saliva composition.  
5. Further research is required in this field as to date 
no product has been developed that completely prevents 
the formation of calculus. 
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